"COVID-19: What Pharmacists Need to Know" offers a multi-module CE webinar curriculum program that delivers current, credible information.
The curriculum features webinars on key issues related to the changing landscape of pharmacy practice in light of COVID-19, each with a different expert faculty presenter:
Webinar 1: "COVID-19 Basics and Effect on Pharmacy Practice," Rupal Mansukhani, Pharm.D., FAPhA, CTTS, on-demand webinar available here.
Webinar 2: "Existing and Investigational Pharmacotherapy for COVID-19," Jason C. Gallagher, Pharm.D., FCCP, FIDP, FIDSA, BCPS, on May 31, at 12:00 p.m. EST.
Webinar 3: "COVID-19: Industry's Response and Caring for Patients on the Front Line," Mary Barna Bridgeman, Pharm.D., BCPS, BCGP, on June 7, at 12:00 p.m. EST.
Webinar 4: "Psychosocial Effects and Quality of Life Impact of COVID-19," Mona K. Patel, Pharm.D., FCCM, BCCCP, on June 14, at 12:00 p.m. EST.
Webinar 5: "Update on COVID-19 Clinical Data and Impact on Reimbursement or Patient Access," Kelly E. Pillinger, Pharm.D., BCPS, BCIDP, on June 28, at 12:00 p.m. EST.
Completing these CE webinars will equip pharmacists with the most up-to-date data available on virology, emerging therapies and vaccines and patient management, as well as mental health, financial and quality of life burdens of COVID-19 on patients and health care personnel. Participants who complete all activities in this series will receive a certificate of completion.
Each activity is accredited by the Accreditation Council for Pharmacy Education and is approved for 0.75 contact hour (0.075 CEU).
This resource center is supported by an educational grant from Pfizer Inc.
Pharmacy Times Continuing Education is in continuing education for retail, health system, managed care and specialty pharmacists. PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PTCE's print, online and live CPE activities are designed to improve the knowledge, competence and skills of pharmacists to better prepare them to provide the highest quality of pharmacy care to the patients they serve and the physicians they assist as part of a multidisciplinary treatment and management team.
PTCE is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.
Merck launches Phase 3 trial for dengue vaccine candidate V181
BioNet and Bio Farma sign MoU on TdaP vaccine
Dx&Vx accelerates universal COVID-19 vaccine development
Moderna withdraws application for flu-COVID combination vaccine pending additional efficacy data
CTP delivers 18,000 sqm Serbian facility for SCHOTT Pharma to support global expansion
LakeShore Biopharma launches novel packaging solution for YSJA rabies vaccine (Vero cell)
Scancell partners with NHS Cancer Vaccine Launch Pad to accelerate melanoma trial recruitment
Orexo reports positive results for powder-based intranasal vaccine using AmorphOX technology
GC Biopharma's BARYTHRAX receives Korean regulatory approval
GSK grants USD2m to boost adult vaccination efforts
Valneva and LimmaTech begin Phase 2 infant trial for Shigella vaccine candidate S4V2
Circio Holding and Entos Pharmaceuticals collaborate on circular RNA delivery
AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100